| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6108631 | Journal of Hepatology | 2009 | 10 Pages |
Abstract
Our data demonstrate that antiviral treatment prevents hepatitis C recurrence in 20% of HCV-infected patients. However, treatment should be recommended with caution in individuals with poor liver function who do not receive norfloxacin prophylaxis for SBP, since it increases the risk of bacterial infections.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jose A. Carrión, Eva MartÃnez-Bauer, Gonzalo Crespo, Santseharay RamÃrez, Sofia Pérez-del-Pulgar, Juan Carlos GarcÃa-Valdecasas, Miquel Navasa, Xavier Forns,